Add like
Add dislike
Add to saved papers

Influence of multiple delays in brain tumor and immune system interaction with T11 target structure as a potent stimulator.

We present a mathematical model which describes the growth of malignant gliomas in presence of immune responses by considering the role of immunotherapeutic agent T11 target structure (T11TS). The model consider five populations, namely, glioma cells, macrophages, cytotoxic T-lymphocytes, TGF - β and IFN - γ. The model system has highly nonlinear terms with four discrete time lags, but remains tractable. The goal of this work is to better understand the effect of multiple delays on the interaction between gliomas and immune components in conjunction with an administration of T11 target structure. Analytically, we investigate the conditions for the asymptotic stability of equilibrium points, the existence of Hopf bifurcations and the maximum value of the delay to preserve the stability of limit cycle. For the set of parameter values estimated from experimental data, time delays have hardly any influence on the system behavior. Numerical simulations are carried out to investigate the dynamics of the model with different values for delays with and without administration of T11 target structure.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app